Lipogenesis in the brain of suckling rats. Studies on the mechansim of mitochondrial-cytosolic carbon transfer.
1. Studies on the incorporation of [3-(14)C]pyruvate and d-3-hydroxy[3-(14)C]butyrate into the brain lipid fraction by brain homogenates of the suckling (7-day-old) rat have been carried out. 2. Whereas approximately twice as much CO(2) was evolved from pyruvate compared with 3-hydroxybutyrate metabolism, similar amounts of the radioactivity of these two precursors were incorporated into the lipid fraction. Furthermore, in both cases the incorporation into lipid was almost tripled when glucose (10mm) or NADPH (2.5mm) was added to the incubation media. 3. If 5mm-(-)-hydroxycitrate, an ATP-citrate lyase inhibitor, was added to the incubation the incorporation of carbon from pyruvate was inhibited to 39% of the control and from 3-hydroxybutyrate to 73% of the control, whereas CO(2) production from both precursors was not affected. 4. The incorporation from pyruvate or 3-hydroxybutyrate into lipids was not affected by the presence of 10mm-glutamate in the medium (to encourage N-acetylaspartate production). However, incorporation from pyruvate was inhibited by 21% in the presence of 5mm-amino-oxyacetate (a transaminase inhibitor) and by 83% in the presence of both hydroxycitrate (5mm) and amino-oxyacetate. 5. Incorporation from 3-hydroxybutyrate into brain lipids was inhibited by 20% by amino-oxyacetate alone, but by 55% in the presence of both hydroxycitrate and amino-oxyacetate. 6. It is concluded that the mechanism of carbon transfer from pyruvate into lipids across the mitochondrial membrane in the suckling rat brain is mainly via citrate and N-acetylaspartate. 3-Hydroxybutyrate, in addition to using these routes, may also be incorporated via acetoacetate formation and transport to the cytosol.
D020155:3-Hydroxybutyric Acid; D001275:ATP Citrate (pro-S)-Lyase / Q000037:antagonists & inhibitors; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D000833:Animals, Suckling; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002951:Citrates / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism; D005260:Female; D006885:Hydroxybutyrates / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis*; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D051381:Rats
D002951:Citrates; D006885:Hydroxybutyrates; D008055:Lipids; D011773:Pyruvates; D000625:Aminooxyacetic Acid; C007999:hydroxycitric acid; D001275:ATP Citrate (pro-S)-Lyase; D020155:3-Hydroxybutyric Acid